DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BOTULISM ANTITOXIN BIVALENT (EQUINE) TYPES A AND B
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
BOTULISM ANTITOXIN BIVALENT (EQUINE) TYPES A AND B
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LANOPEPDEN MESYLATE
1
Small molecule
Investigational
Unknown
Unknown
Infections
Unknown
LANOPEPDEN MESYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
YW25HPP501
Molecule Type:
Small molecule
Molecular Formula:
C23H38FN7O7S
Molecular Weight:
575.66
AlogP:
0.93
PSA:
123.16
HBD:
3.0
HBA:
#RotB:
9.0
Source:
BIAPENEM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
BIAPENEM
×
Maximum Phase:
1
First Approval:
None
UNII:
YR5U3L9ZH1
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O4S
Molecular Weight:
350.4
AlogP:
-1.89
PSA:
102.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CARBOMER 980
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CARBOMER 980
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-923295A
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
GSK-923295A
×
Maximum Phase:
1
First Approval:
None
UNII:
072702W9QD
Molecule Type:
Small molecule
Molecular Formula:
C32H38ClN5O4
Molecular Weight:
592.14
AlogP:
4.51
PSA:
108.2
HBD:
3.0
HBA:
#RotB:
12.0
Source:
CRS-3123
1
Small molecule
Investigational
Unknown
Unknown
Clostridium Infections; Infections
Methionine--tRNA ligase inhibitor
CRS-3123
×
Maximum Phase:
1
First Approval:
None
UNII:
2P987FW4E8
Molecule Type:
Small molecule
Molecular Formula:
C19H19Br2N3O2S
Molecular Weight:
513.26
AlogP:
5.03
PSA:
66.15
HBD:
3.0
HBA:
#RotB:
6.0
Source:
GI HEPTAPEPTIDE
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
GI HEPTAPEPTIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
D33CAJ796A
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NORLEUCINE
1
Small molecule
Investigational
Unknown
Unknown
Hot Flashes
Unknown
NORLEUCINE
×
Maximum Phase:
1
First Approval:
None
UNII:
832C8OV84S
Molecule Type:
Small molecule
Molecular Formula:
C6H13NO2
Molecular Weight:
131.18
AlogP:
0.59
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TTI-622
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Multiple Myeloma
Unknown
TTI-622
×
Maximum Phase:
1
First Approval:
None
UNII:
44D51T6SZH
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYC065
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CYC065
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALANOLIDE A
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
CALANOLIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
S5A9TQN46W
Molecule Type:
Small molecule
Molecular Formula:
C22H26O5
Molecular Weight:
370.45
AlogP:
4.38
PSA:
68.9
HBD:
1.0
HBA:
#RotB:
2.0
Source:
E-2212
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
E-2212
×
Maximum Phase:
1
First Approval:
None
UNII:
V9KGF25853
Molecule Type:
Small molecule
Molecular Formula:
C25H23F3N6O
Molecular Weight:
480.49
AlogP:
5.29
PSA:
70.65
HBD:
0.0
HBA:
#RotB:
5.0
Source:
D-FLUOROMETHYLTYROSINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-FLUOROMETHYLTYROSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
GSM7N3U4J8
Molecule Type:
Small molecule
Molecular Formula:
C10H12FNO3
Molecular Weight:
213.21
AlogP:
0.95
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BAKUCHIOL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BAKUCHIOL
×
Maximum Phase:
1
First Approval:
None
UNII:
OT12HJU3AR
Molecule Type:
Small molecule
Molecular Formula:
C18H24O
Molecular Weight:
256.39
AlogP:
5.34
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PF-05180999
1
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders; Schizophrenia
Unknown
PF-05180999
×
Maximum Phase:
1
First Approval:
None
UNII:
5L84K4IEN9
Molecule Type:
Small molecule
Molecular Formula:
C19H17F3N8
Molecular Weight:
414.4
AlogP:
3.12
PSA:
77.03
HBD:
0.0
HBA:
#RotB:
3.0
Source:
RXDX-105
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RXDX-105
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MU-J591
1
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
MU-J591
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
OXYNTOMODULIN
1
Protein
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Obesity
Unknown
OXYNTOMODULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
C192H295N59O60S
Molecular Weight:
4421.89
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PROFILNINE SD
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PROFILNINE SD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
.ALPHA.-PYRROLIDINONONANOPHENONE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
.ALPHA.-PYRROLIDINONONANOPHENONE
×
Maximum Phase:
1
First Approval:
None
UNII:
S3FKL8RY1D
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO
Molecular Weight:
287.45
AlogP:
4.69
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
9.0
Source:
NG-NITRO-L-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NG-NITRO-L-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMC-EB10
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid
Tyrosine-protein kinase receptor FLT3 inhibitor
IMC-EB10
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LETRAZURIL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LETRAZURIL
×
Maximum Phase:
1
First Approval:
None
UNII:
U8736VCB22
Molecule Type:
Small molecule
Molecular Formula:
C17H9Cl2FN4O2
Molecular Weight:
391.19
AlogP:
3.02
PSA:
91.54
HBD:
1.0
HBA:
#RotB:
3.0
Source:
2-DEOXYGLUCOSE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
2-DEOXYGLUCOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANSOFAXINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ANSOFAXINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
USL-311
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Unknown
USL-311
×
Maximum Phase:
1
First Approval:
None
UNII:
2BTG5MX2Q2
Molecule Type:
Small molecule
Molecular Formula:
C24H34N6O
Molecular Weight:
422.58
AlogP:
3.11
PSA:
64.6
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BMS-962476
1
Unknown
Investigational
Unknown
Unknown
Atherosclerosis
Unknown
BMS-962476
×
Maximum Phase:
1
First Approval:
None
UNII:
OSI903EJOV
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MAFOSFAMIDE
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Leukemia; Lymphoma; Meningeal Neoplasms
Unknown
MAFOSFAMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
5970HH9923
Molecule Type:
Small molecule
Molecular Formula:
C9H19Cl2N2O5PS2
Molecular Weight:
401.27
AlogP:
1.83
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
BMS-188797
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
BMS-188797
×
Maximum Phase:
1
First Approval:
None
UNII:
0HG7S0S581
Molecule Type:
Small molecule
Molecular Formula:
C47H51NO15
Molecular Weight:
869.92
AlogP:
3.96
PSA:
230.52
HBD:
4.0
HBA:
#RotB:
10.0
Source:
ATIPAMEZOLE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ATIPAMEZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
03N9U5JAF6
Molecule Type:
Small molecule
Molecular Formula:
C14H16N2
Molecular Weight:
212.3
AlogP:
2.86
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CXB722
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CXB722
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EM-1421
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EM-1421
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TCN-202
1
Unknown
Investigational
Unknown
Unknown
Cytomegalovirus Infections
Unknown
TCN-202
×
Maximum Phase:
1
First Approval:
None
UNII:
Y305H9E76N
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IOFOLASTAT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IOFOLASTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
9T6EBU5ER1
Molecule Type:
Small molecule
Molecular Formula:
C19H26IN3O7
Molecular Weight:
535.34
AlogP:
1.62
PSA:
165.06
HBD:
6.0
HBA:
#RotB:
14.0
Source:
1
2
…
99
100
101
102
103
104
105
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA